Neuronetics STIM Medical Device — Cost of Goods Sold

Other segment segments

Similar metrics at other companies

MEIMedical — Cost of Goods Sold

$0—

OMProduct — Cost of Goods Sold

$8.83M-19.7%

RELLHealthcare — Cost of Goods Sold

$1.74M-17.2%

ABTMedical Devices — Cost of products sold, excluding amortization of intangible assets

$1.81B+13.5%

ACLSProduct — Cost of Goods Sold

$105.74M+11.9%

ANGOMed Device — Cost of sales (exclusive of intangible amortization)

$22.95M+7.3%

Questions, answered.

What is Neuronetics's medical device — cost of goods sold?

Neuronetics (STIM) reported medical device — cost of goods sold of $2.86M in Q1 2026.

How has Neuronetics's medical device — cost of goods sold changed year-over-year?

Neuronetics's medical device — cost of goods sold decreased by 9.3% year-over-year, from $3.15M to $2.86M.

What is the long-term trend for Neuronetics's medical device — cost of goods sold?

Over 2 years (2022 to 2024), Neuronetics's medical device — cost of goods sold has grown at a 6.4% compound annual growth rate (CAGR), from $15.48M to $17.52M.

What does medical device — cost of goods sold mean?

This metric captures the direct costs attributable to the production and delivery of medical devices and associated services. It includes expenses such as raw materials, direct labor, and manufacturing overhead, providing insight into the direct cost efficiency of the segment's operations.